Original Research
Accepted on 22 Aug 2025
Chrysin sensitizes glioblastoma cells and spheroids to temozolomide treatment by reducing EMT and stemness phenotypes, as well as targeting multidrug resistance proteins
in Experimental Pharmacology and Drug Discovery